These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25232193)

  • 1. Downregulation of Ca2+-activated Cl- channel TMEM16A by the inhibition of histone deacetylase in TMEM16A-expressing cancer cells.
    Matsuba S; Niwa S; Muraki K; Kanatsuka S; Nakazono Y; Hatano N; Fujii M; Zhan P; Suzuki T; Ohya S
    J Pharmacol Exp Ther; 2014 Dec; 351(3):510-8. PubMed ID: 25232193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Ca(2+)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma.
    Liu W; Lu M; Liu B; Huang Y; Wang K
    Cancer Lett; 2012 Dec; 326(1):41-51. PubMed ID: 22820160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells.
    Cao QF; Qian SB; Wang N; Zhang L; Wang WM; Shen HB
    Cancer Biother Radiopharm; 2015 Mar; 30(2):87-93. PubMed ID: 25760728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of the Ca²⁺-activated Cl⁻ channel DOG1/TMEM16A in gastrointestinal stromal tumor cells.
    Berglund E; Akcakaya P; Berglund D; Karlsson F; Vukojević V; Lee L; Bogdanović D; Lui WO; Larsson C; Zedenius J; Fröbom R; Bränström R
    Exp Cell Res; 2014 Aug; 326(2):315-25. PubMed ID: 24825187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.
    Li J; Zhang T; Yang F; He Y; Dai F; Gao D; Chen Y; Liu M; Yi Z
    Br J Pharmacol; 2015 Aug; 172(15):3817-30. PubMed ID: 25884486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
    Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
    Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells.
    Sui Y; Sun M; Wu F; Yang L; Di W; Zhang G; Zhong L; Ma Z; Zheng J; Fang X; Ma T
    PLoS One; 2014; 9(12):e115443. PubMed ID: 25541940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer.
    Li ZH; Zhang XB; Han XQ; Feng CR; Wang FS; Wang PG; Shen J; Shi YK
    Oncol Rep; 2013 Jul; 30(1):499-505. PubMed ID: 23624828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
    Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
    Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
    Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells.
    Cheng HT; Hung WC
    Oncol Rep; 2013 Mar; 29(3):1238-44. PubMed ID: 23242251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN.
    Shiwarski DJ; Shao C; Bill A; Kim J; Xiao D; Bertrand CA; Seethala RS; Sano D; Myers JN; Ha P; Grandis J; Gaither LA; Puthenveedu MA; Duvvuri U
    Clin Cancer Res; 2014 Sep; 20(17):4673-88. PubMed ID: 24919570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMEM16A is a Ca(2+) -activated Cl(-) channel expressed in the renal collecting duct.
    Svenningsen P; Nielsen MR; Marcussen N; Walter S; Jensen BL
    Acta Physiol (Oxf); 2014 Oct; 212(2):166-74. PubMed ID: 24913262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
    Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
    Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
    Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Novel TMEM16A Inhibitor Dehydroandrographolide and Its Anticancer Activity on SW620 Cells.
    Sui Y; Wu F; Lv J; Li H; Li X; Du Z; Sun M; Zheng Y; Yang L; Zhong L; Zhang X; Zhang G
    PLoS One; 2015; 10(12):e0144715. PubMed ID: 26657333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-κB signaling pathway.
    Liu J; Liu Y; Ren Y; Kang L; Zhang L
    Mol Med Rep; 2014 Mar; 9(3):1068-74. PubMed ID: 24401903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
    Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
    Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.